Philip Morris International Valuation
Is PM * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PM * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PM * (MX$1655) is trading below our estimate of fair value (MX$2142.7)
Significantly Below Fair Value: PM * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PM *?
Other financial metrics that can be useful for relative valuation.
What is PM *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$151.27b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5.5x |
Enterprise Value/EBITDA | 14.2x |
PEG Ratio | 1.9x |
Price to Earnings Ratio vs Peers
How does PM *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 18.4x | ||
FEMSA UBD Fomento Económico Mexicano. de | 26.1x | 14.5% | Mex$657.7b |
BIMBO A Grupo Bimbo. de | 22.3x | 18.7% | Mex$317.5b |
AC * Arca Continental. de | 16.2x | 7.9% | Mex$284.7b |
MO Altria Group | 8.9x | 2.5% | US$75.5b |
PM * Philip Morris International | 19.1x | 10.1% | Mex$151.3b |
Price-To-Earnings vs Peers: PM * is expensive based on its Price-To-Earnings Ratio (19.1x) compared to the peer average (18.5x).
Price to Earnings Ratio vs Industry
How does PM *'s PE Ratio compare vs other companies in the Global Tobacco Industry?
Price-To-Earnings vs Industry: PM * is expensive based on its Price-To-Earnings Ratio (19.1x) compared to the Global Tobacco industry average (12.1x).
Price to Earnings Ratio vs Fair Ratio
What is PM *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 19.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PM *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,655.00 | Mex$1,858.63 +12.3% | 9.0% | Mex$2,277.21 | Mex$1,461.49 | n/a | 15 |
Apr ’25 | Mex$1,500.00 | Mex$1,815.15 +21.0% | 9.5% | Mex$2,253.67 | Mex$1,429.56 | n/a | 15 |
Mar ’25 | Mex$1,525.00 | Mex$1,818.60 +19.3% | 10.4% | Mex$2,284.97 | Mex$1,449.42 | n/a | 16 |
Feb ’25 | Mex$1,510.00 | Mex$1,853.47 +22.7% | 10.7% | Mex$2,298.21 | Mex$1,466.39 | n/a | 16 |
Jan ’25 | Mex$1,570.00 | Mex$1,863.29 +18.7% | 9.1% | Mex$2,231.83 | Mex$1,467.86 | n/a | 18 |
Dec ’24 | Mex$1,615.00 | Mex$1,887.76 +16.9% | 9.1% | Mex$2,250.77 | Mex$1,480.31 | n/a | 18 |
Nov ’24 | Mex$1,614.00 | Mex$1,979.09 +22.6% | 8.6% | Mex$2,346.96 | Mex$1,543.57 | n/a | 17 |
Oct ’24 | Mex$1,610.00 | Mex$1,991.28 +23.7% | 7.7% | Mex$2,282.18 | Mex$1,527.30 | n/a | 17 |
Sep ’24 | Mex$1,624.00 | Mex$1,913.14 +17.8% | 8.2% | Mex$2,199.87 | Mex$1,472.22 | n/a | 18 |
Aug ’24 | Mex$1,670.30 | Mex$1,922.02 +15.1% | 8.2% | Mex$2,207.92 | Mex$1,477.61 | n/a | 18 |
Jul ’24 | Mex$1,676.00 | Mex$1,932.60 +15.3% | 8.2% | Mex$2,225.54 | Mex$1,489.40 | n/a | 18 |
Jun ’24 | Mex$1,591.80 | Mex$2,032.83 +27.7% | 8.0% | Mex$2,336.36 | Mex$1,617.48 | n/a | 18 |
May ’24 | Mex$1,780.00 | Mex$2,040.77 +14.7% | 7.9% | Mex$2,343.19 | Mex$1,622.21 | Mex$1,673.00 | 18 |
Apr ’24 | Mex$1,681.12 | Mex$2,043.29 +21.5% | 8.4% | Mex$2,342.91 | Mex$1,622.02 | Mex$1,500.00 | 16 |
Mar ’24 | Mex$1,800.00 | Mex$2,025.62 +12.5% | 8.6% | Mex$2,353.38 | Mex$1,629.26 | Mex$1,525.00 | 19 |
Feb ’24 | Mex$1,946.00 | Mex$2,006.46 +3.1% | 10.0% | Mex$2,420.73 | Mex$1,675.89 | Mex$1,510.00 | 19 |
Jan ’24 | Mex$1,962.00 | Mex$2,074.66 +5.7% | 10.2% | Mex$2,514.27 | Mex$1,702.58 | Mex$1,570.00 | 18 |
Dec ’23 | Mex$1,964.50 | Mex$1,982.73 +0.9% | 9.5% | Mex$2,452.71 | Mex$1,660.89 | Mex$1,615.00 | 17 |
Nov ’23 | Mex$1,830.00 | Mex$2,018.30 +10.3% | 10.2% | Mex$2,530.06 | Mex$1,693.34 | Mex$1,614.00 | 17 |
Oct ’23 | Mex$1,706.60 | Mex$2,194.12 +28.6% | 7.1% | Mex$2,555.62 | Mex$1,871.44 | Mex$1,610.00 | 17 |
Sep ’23 | Mex$1,867.10 | Mex$2,181.83 +16.9% | 7.3% | Mex$2,538.35 | Mex$1,858.79 | Mex$1,624.00 | 16 |
Aug ’23 | n/a | Mex$2,234.87 0% | 7.6% | Mex$2,609.01 | Mex$1,910.54 | Mex$1,670.30 | 16 |
Jul ’23 | Mex$2,049.00 | Mex$2,241.58 +9.4% | 6.1% | Mex$2,556.62 | Mex$1,912.44 | Mex$1,676.00 | 16 |
Jun ’23 | Mex$2,143.00 | Mex$2,170.71 +1.3% | 7.6% | Mex$2,541.75 | Mex$1,826.51 | Mex$1,591.80 | 16 |
May ’23 | n/a | Mex$2,222.66 0% | 9.2% | Mex$2,612.59 | Mex$1,842.99 | Mex$1,780.00 | 17 |
Analyst Forecast: Target price is less than 20% higher than the current share price.